Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus

Replies to post #224234 on Biotech Values

Replies to #224234 on Biotech Values
icon url

DewDiligence

03/21/19 5:21 PM

#224236 RE: rfj1862 #224234

Most of ENTA's current EV derives from the Mavyret royalty stream, which is running at $200M per year (pre-tax). I.e. investors are not paying so much for the NASH/PBC, RSV, and HBV programs.